SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors

Various studies have shown that SARS-CoV-2 is a highly immunogenic virus. It is known that different types of immunogenic viral pathogens could trigger the formation of HLA antibodies. Therefore, there is a concern that the SARS-CoV-2 could also induce the development of HLA antibodies in volunteers...

Descripción completa

Detalles Bibliográficos
Autores principales: Dada, Ashraf, Elhassan, Khalid, Bawayan, Rayan Mohammed, Albishi, Ghadeer, Hefni, Lama, Bassi, Sawsan, Sobahy, Turki, Cupler, Edward, AlBaz, Nabeela, Wali, Ghassan, Alraddadi, Basem, Alshukairi, Abeer N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148903/
https://www.ncbi.nlm.nih.gov/pubmed/35378533
http://dx.doi.org/10.1159/000524016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148903/
https://www.ncbi.nlm.nih.gov/pubmed/35378533
http://dx.doi.org/10.1159/000524016

Ejemplares similares